ABIVAX (EPA:ABVX) | WebDisclosure

PRESS RELEASE

published on 08/12/2026 at 18:00, 2 months 24 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
ABIVAX publie les informations relatives au nombre total de droits de vote et d'actions conformément aux réglementations en vigueur. Abivax est une société de biotechnologie au stade clinique axée sur le développement de traitements thérapeutiques

Droits De Vote Biotechnologie Abivax Traiements Thérapeutiques Régulation De L’organisme
PRESS RELEASE

published on 08/12/2026 at 18:00, 2 months 24 days ago

ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.26
ABIVAX annonce le nombre d'actions et de droits de vote au 31/07/26 conformément à la réglementation financière. Siège social à Paris. Focus sur le développement clinique de phase 3 de son candidat médicament ABX464

Droits De Vote Actions Abivax Développement Clinique ABX464
BRIEF

published on 07/30/2026 at 22:10, 3 months 6 days ago

Abivax Advances with FDA on Obefazimod for Ulcerative Colitis

Abivax Obefazimod Ulcerative Colitis NDA Submission FDA Interaction
BRIEF

published on 07/30/2026 at 22:10, 3 months 6 days ago

Abivax reçoit un retour positif de la FDA pour l'obéfazimod

FDA Abivax Obefazimod Rectocolite Hémorragique Autorisation De Mise Sur Le Marché
BRIEF

published on 07/30/2026 at 22:10, 3 months 6 days ago

Abivax receives positive feedback from the FDA for obefazimod

FDA Abivax Obefazimod Ulcerative Colitis Marketing Authorization
BRIEF

published on 07/30/2026 at 22:10, 3 months 6 days ago

Abivax obtient des avancées auprès de la FDA concernant l'obefazimod pour le traitement de la colite ulcéreuse

Abivax Obefazimod Rectocolite Hémorragique Soumission D'un Accord De Confidentialité Interaction Avec La FDA
PRESS RELEASE

published on 07/30/2026 at 22:05, 3 months 6 days ago

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Abivax announces positive pre-NDA interaction with FDA for Obefazimod, on track for NDA submission by end of 2026, reinforcing potential in treating ulcerative colitis

FDA Abivax Obefazimod Ulcerative Colitis NDA Submission
PRESS RELEASE

published on 07/30/2026 at 22:05, 3 months 6 days ago

Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod
Abivax annonce un retour positif de la FDA à l’issue de ses échanges pré-NDA concernant l’obéfazimod. La société se prépare à déposer sa première NDA d'ici fin 2026

FDA Abivax Obefazimod Rectocolite Hémorragique NDA
BRIEF

published on 07/24/2026 at 09:51, 3 months 12 days ago

Sofinnova Partners crosses threshold in ABIVAX

Euronext Paris Voting Rights Abivax Threshold Crossing Sofinnova Partners
BRIEF

published on 07/24/2026 at 09:51, 3 months 12 days ago

Franchissement de seuil par Sofinnova Partners dans ABIVAX

Euronext Paris Droits De Vote Franchissement De Seuil Abivax Sofinnova Partners

Published on 11/06/2026 at 01:20, 16 minutes ago

Presentation to Munich Mining Conference
Published on 11/06/2026 at 00:53, 43 minutes ago

Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 51 minutes ago

Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:55, 1 hour 41 minutes ago

Santé Canada autorise deux vaccins à ARNm de Moderna : un vaccin contre la grippe et un vaccin combiné contre la grippe et la COVID-19
Published on 11/05/2026 at 23:20, 2 hours 16 minutes ago

Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines

View all ACCESSWIRE

Published on 11/06/2026 at 00:05, 1 hour 31 minutes ago

RBI: Announcement of the result of the voluntary public tender offer for all Addiko shares following expiration of the grace period
Published on 11/05/2026 at 22:05, 3 hours 31 minutes ago

Quantinuum Reports Third Quarter 2026 Results and Raises Full-Year Revenue Outlook
Published on 11/05/2026 at 20:38, 4 hours 58 minutes ago

freenet uses funds from Ceconomy sale for waipu.tv acquisition and share buyback
Published on 11/05/2026 at 20:37, 4 hours 59 minutes ago

EQS-Adhoc: freenet AG decides on share buyback programme for up to EUR 75 million
Published on 11/05/2026 at 19:45, 5 hours 50 minutes ago

Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets

View all EQS

Published on 11/05/2026 at 18:21, 7 hours 14 minutes ago

Capital et droits de vote au 31 octobre 2026
Published on 11/05/2026 at 18:21, 7 hours 14 minutes ago

Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 18:01, 7 hours 34 minutes ago

LNA SANTE : Chiffre d'Affaires T3 2026
Published on 11/05/2026 at 17:50, 7 hours 46 minutes ago

NRJ GROUP - Financial information Q3 2026
Published on 11/05/2026 at 17:50, 7 hours 46 minutes ago

NRJ GROUP - Information financière T3 2026

View all LES ECHOS COMFI WIRE

News